Condition

Myelodysplastic/Myeloproliferative Neoplasms clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Myelodysplastic/Myeloproliferative Neoplasms clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Canada (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Myelodysplastic/Myeloproliferative Neoplasms clinical trials

StudyPhaseWhereStatusRegistered
OURA ring wearable monitoring for adults with myelodysplastic syndromes — Toronto, Ontario Recruiting Feb 21, 2024
Registry of older patients with cancer — Boone, North Carolina and 6 other locations Recruiting Jun 4, 2010
Collection of tissue, blood, and body fluid samples from patients with hematologic cancer — Chapel Hill, North Carolina Recruiting Jun 4, 2010

All recruiting trials (3)

Related topics

Myelodysplastic SyndromesLeukemiaLymphomaLymphoproliferative DisorderMultiple Myeloma and Plasma Cell NeoplasmMDSUnspecified Adult Solid Tumor, Protocol Specific

Quick answers

How many Myelodysplastic/Myeloproliferative Neoplasms clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.